Latest Tau protein Stories
NEW YORK, Nov. 11, 2010 /PRNewswire/ -- Oligomerix, Inc.
Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimerâ€™s disease and other neurological disorders of the brain.
Cells that help to protect the central nervous system may also contribute to pathological changes in the brain.
A new study uncovers a protein modification that may contribute to the formation of neuron-damaging neurofibrillary tangles in the human brain.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have uncovered new approaches to reduce toxic proteins in Alzheimer's disease (AD) and other neurodegenerative diseases.
An international team of Alzheimerâ€™s disease experts, led by Washington University School of Medicine in St. Louis, has uncovered a gene variation that appears to predict the rate at which Alzheimerâ€™s disease will progress.
Whitehead Institute researchers have determined a key part of how cells regulate the chromosome/microtubule interface, which is central to proper chromosomal distribution during cell division.
Uncovers new explanation for the spread of key protein within the brain
WASHINGTON, Feb. 25 /PRNewswire/ -- Complementary approaches to Alzheimer's research were recognized as four scientists received the prestigious MetLife Foundation Awards for Medical Research in Alzheimer's Disease in Washington, D.C. during a scientific briefing and luncheon. Todd E.
Nearly 20 years ago Huntington Potter kicked up a storm of controversy with the idea that Down syndrome and Alzheimerâ€™s were the same disease -- Now the evidence is in: He was right.
- An armed gangster.